Evolva Holding SA (0QQJ.L)
| Previous close | 0.0861 |
| Open | 0.0853 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.0853 - 0.0853 |
| 52-week range | 0.0853 - 0.0853 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 63.151M |
| Beta (5Y monthly) | 0.61 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0480 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- EQS Group
Evolva successfully placed shares from authorized capital, raising CHF 6.3 million
Evolva Holding SA / Key word(s): Financing24-May-2022 / 07:01 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad Hoc Announcement (PDF)PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Successful private placement with several long-term oriented institutional investors, underlining trust in new leadership team Selected Board members and management personally participated with CHF 1.0 million, demonstra
- EQS Group
Evolva business update: On track to reach 2022 guidance
Evolva Holding SA / Key word(s): Miscellaneous19-May-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad Hoc Announcement (PDF)PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Evolva is on track to reach its targeted revenue growth of 50% in 2022 and a positive, double-digit gross contribution margin The two recently announced customer orders above the CHF 1 million threshold underline the
- EQS Group
Evolva signs distribution agreement for its Veri-teTM Resveratrol for dietary supplements in Brazil
Evolva Holding SA / Key word(s): Agreement/Development of Sales12-May-2022 / 07:01 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad Hoc Announcement (PDF)PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Distribution agreement signed with Tovani Benzaquen Ingredients to jointly develop the Brazilian business Minimum revenues of CHF 1.5 million expected from the partnership Reinach, May 12, 2022 – Evo
